Data / Drug companies / Glucagon
Glucagon: 9 companies and 18 products in the FDA NDC directory
Glucagon is listed in the FDA National Drug Code Directory by 9 companies, with 18 products in commercial distribution. 8 of the products (44.4%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are kit; powder; injection, powder, lyophilized, for solution, and the newest product started marketing on October 8, 2025.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 9
- Products
- 18
- Generic (ANDA) products
- 8 (44.4%)
- Application numbers
- 6
- Routes
- Nasal, Intramuscular, Intravenous, Oral
- Brand names
- Baqsimi
- openFDA record search
- api.fda.gov
Companies that list glucagon
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Fresenius Kabi USA, LLC | 5 | kit; injection, powder, lyophilized, for solution | New drug applications (NDA) | September 9, 2019 |
| Sportpharm LLC | 4 | kit; powder | Generic drugs (ANDA) | October 8, 2025 |
| Amphastar Pharmaceuticals, Inc. | 3 | powder; kit | New drug applications (NDA) | February 10, 2021 |
| A-S Medication Solutions | 1 | kit | Generic drugs (ANDA) | February 10, 2021 |
| Cipla USA Inc. | 1 | kit | Generic drugs (ANDA) | October 8, 2025 |
| HF Acquisition Co LLC, DBA HealthFirst | 1 | kit | New drug applications (NDA) | March 10, 2020 |
| Lupin Pharmaceuticals, Inc. | 1 | kit | Generic drugs (ANDA) | August 4, 2025 |
| Mylan Pharmaceuticals Inc. | 1 | kit | Generic drugs (ANDA) | February 26, 2025 |
| Professional Complementary Health Formulas | 1 | liquid | Unapproved homeopathic products | August 15, 1984 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Kit | 12 | 66.7% |
| Powder | 3 | 16.7% |
| Injection, powder, lyophilized, for solution | 2 | 11.1% |
| Liquid | 1 | 5.6% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| New drug applications (NDA) | 9 | 50% |
| Generic drugs (ANDA) | 8 | 44.4% |
| Unapproved homeopathic products | 1 | 5.6% |
Pharmacologic classes
| Class | Products |
|---|---|
| Antihypoglycemic Agent | 6 |
| Gastrointestinal Motility Inhibitor | 6 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.